Deepa Pakianathan is listed as a director on 11 SEC Form D filings by 3 issuers between May 2010 and Jul 2014: Relypsa Inc (Santa Clara, CA — pharmaceuticals — 2010–2012; $70.1M reported sold to 15 investors), Calithera Biosciences, Inc. (South San Francisco, CA — biotechnology — 2011–2014; $27.1M reported sold to 19 investors) and OncoMed Pharmaceuticals Inc (Redwood City, CA — biotechnology — 2013; $22.2M reported sold to 1 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $119.5M sold in total.
Listed alongside Gerrit Klaerner (6 shared filings), Jerry M. Buysse (6 shared filings), Ronald Krasnow (6 shared filings), Scott Rocklage (6 shared filings), Jean George (4 shared filings) and 31 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Deepa. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 11 public filings for Deepa Pakianathan and found 11 differences, 1 worth asking the sponsor about: Deepa Pakianathan is no longer listed on the Dec 11, 2012 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.